An innovation in glaucoma surgery: XEN45 gel stent implantation

Basit Öğe Kaydı
dc.authoridGüçlü, Hande/0000-0002-3021-0493
dc.authoridOzal, Sadik Altan/0000-0003-0078-1049
dc.authorwosidGüçlü, Hande/AAW-9756-2020
dc.authorwosidOzal, Sadik Altan/B-5123-2019
dc.contributor.authorOzal, Sadik Altan
dc.contributor.authorKaplaner, Osman
dc.contributor.authorBasar, Baybars Baris
dc.contributor.authorGuclu, Hande
dc.contributor.authorOzal, Ece
dc.date.accessioned2024-06-12T11:02:39Z
dc.date.available2024-06-12T11:02:39Z
dc.date.issued2017
dc.departmentTrakya Üniversitesien_US
dc.description.abstractPurpose: To report follow-up data for patients who underwent XEN45 gel stent implantation, a new method of minimally invasive glaucoma surgery. Methods: Fifteen eyes in fifteen patients who underwent XEN45 gel stent implantation surgery were investigated in the study. All patients were examined preoperatively and at the following postoperative time points: 1 day; 1 and 2 weeks; and 1, 2, 3, 6, and 12 months. Intraocular pressure (IOP) was measured via Goldmann applanation tonometry. Combined surgical procedures (XEN45 + phacoemulsification + intraocular lens) were performed in patients who that had cataracts in addition to glaucoma. Results: The mean IOP values were significantly lower than the preoperative values at all postoperative visits (p<0.001). In two patients, the IOP exceeded 20 mmHg 12 months after surgery. These IOP increases were controlled by medical therapy, and none of the patients needed another surgical procedure. Conclusion: XEN45 gel stent implantation is a minimally invasive glaucoma surgery that ensures the effective reduction of IOP. This new treatment modality also avoids the destructive complications encountered in other invasive surgical procedures. However, further studies with greater numbers of patients and longer follow-up periods are needed to clarify certain points.en_US
dc.identifier.doi10.5935/0004-2749.20170093
dc.identifier.endpage385en_US
dc.identifier.issn0004-2749
dc.identifier.issn1678-2925
dc.identifier.issue6en_US
dc.identifier.pmid29267575en_US
dc.identifier.scopus2-s2.0-85038391946en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage382en_US
dc.identifier.urihttps://doi.org/10.5935/0004-2749.20170093
dc.identifier.urihttps://hdl.handle.net/20.500.14551/21373
dc.identifier.volume80en_US
dc.identifier.wosWOS:000418526100010en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherConsel Brasil Oftalmologiaen_US
dc.relation.ispartofArquivos Brasileiros De Oftalmologiaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectGlaucoma Open-Angle/Surgeryen_US
dc.subjectTrabeculectomyen_US
dc.subjectMinimally Invasive Surgical Procedure, Stenten_US
dc.subjectOpen-Angle Glaucomaen_US
dc.subjectTrabeculectomyen_US
dc.subjectOutcomesen_US
dc.subjectPrevalenceen_US
dc.titleAn innovation in glaucoma surgery: XEN45 gel stent implantationen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu